Showing results (1461-1470 of 1,619) with videos related to

Sort By:
Pageof 162
Journal of Mass Spectrometry : JMS|November 22, 2013
Mass spectrometry imaging as a tool for surgical decision-makingDavid Calligaris, Isaiah Norton, Daniel R Feldman, et al.
Cutis|November 6, 2010
Optimizing topical therapies for treating psoriasis: a consensus conferenceJoshua A Zeichner, Mark G Lebwohl, Alan Menter, et al.
Journal of Cutaneous Medicine and Surgery|March 22, 2002
Betamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a single-blind, open-label study in the treatment of scalp psoriasisS R Feldman, S M Ravis, A B Fleischer, et al.
The Journal of Animal Ecology|March 22, 2020
The geographic mosaic in parallel: Matching patterns of newt tetrodotoxin levels and snake resistance in multiple predator-prey pairsJessica S Reimche, Edmund D Brodie, Amber N Stokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer SurvivorsMatthew R Trendowski, Heather E Wheeler, Omar El-Charif, et al.
Cancer|March 23, 2012
Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitorsYevgeniy Balagula, Alyx Rosen, Belinda H Tan, et al.
The British Journal of Dermatology|September 25, 2016
Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoringH Alinia, S Moradi Tuchayi, J A Smith, et al.
BJU International|November 4, 2025
Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health-related quality of life instrumentSamuel A Gold, Amy L Tin, Viranda H Jayalath, et al.
The Journal of Urology|February 13, 2014
Clinical outcomes of local and metastatic testicular sex cord-stromal tumorsJonathan L Silberstein, Wassim M Bazzi, Emily Vertosick, et al.
BMC Urology|July 4, 2020
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinationsYasser Ged, Ruby Gupta, Cihan Duzgol, et al.
Pageof 162